Hostname: page-component-7c8c6479df-24hb2 Total loading time: 0 Render date: 2024-03-28T09:55:39.869Z Has data issue: false hasContentIssue false

Gilles De La Tourette's Disease

Published online by Cambridge University Press:  29 January 2018

Per Dalén*
Affiliation:
University of Göteborg, Psychiatric Research Centre, St. Jörgen's Hospital, 42203 Hisings Backa, Sweden
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1973 

References

1. Klawans, H. L. Jr. (1973). ‘The pharmacology of tardive dyskinesias.Amer. J. Psychiat., 130, 82–6.Google Scholar
2. Ungerstedt, U. (1970). ‘Mechanism of action of L-dopa studied in an experimental parkinson model’, in Monoamines, Noyaux Gris Centraux et Syndrome de Parkinson: Symposium Bel-Air IV. Geneva.Google Scholar
3. Dalén, P. (1973). ‘Lithium therapy in Huntington's chorea and tardive dyskinesia.Lancet, i, 107–8.Google Scholar
4. Mattsson, B. (1973). ‘Huntington's chorea and lithium therapy.Lancet, i, 718–9.Google Scholar
5. Manyam, N. V. B., and Bravo-Fernandez, E. (1973). ‘Lithium carbonate in Huntington's chorea.Lancet, i, 1010.Google Scholar
6. Prange, A. J. Jr., Wilson, I. C., Morris, G. E., and Hall, C. D. (1973). ‘Preliminary experience with tryptophan and lithium in the treatment of tardive dyskinesia.Psychopharm. Bull., 9 (Jan), 36–7.Google Scholar
7. Simpson, G. M. (1973). ‘Tardive dyskinesia.Brit. J. Psychiat., 122, 618.Google Scholar
8. Dalén, P., and Steg, G. (1973). ‘Lithium and levodopa in parkinsonism.Lancet, i, 936–7.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.